In summary, these results suggest that the anti-tumor effects of zebularine depend on the co-existence of CD4+ and CD8+ T lymphocytes and the presence of CD4+ T cells is necessary for CTLs to kill tumor cells. Here, CD4 is linked to neoplasm.